A vaccine called Gardasil has been developed that protects against the two high-risk HPV types (types 16 and 18), which cause 70% of cervical cancers in women and 90% of all HPV-related cancers in men. It also protects against two low-risk HPV types (types 6 and 11), which cause 90% of genital warts.
Australia's Professor Ian Frazer and his team at the University of Queensland discovered how to make the vaccine particles, which form the basis of the HPV vaccine.
Gardasil is used in the school-based National HPV Vaccination Program.
Another vaccine called Cervarix is available, which protects against the same two high-risk HPV types (types 16 and 18). It does not protect against low-risk HPV types which cause genital warts. Some doctors may recommend this vaccine rather than Gardasil.
Over 205 million doses of the Gardasil vaccine have been distributed worldwide as of 31 December 2015.
For further information about the 2 vaccines available in Australia that provide protection against HPV infections, refer to the Australian Immunisation Handbook.